Pimagedine: Started Phase II study in 90 patients in Israel and 30 patients in the U.S.

Alteon Inc. (ALTN), Ramsey, N.J. Product: Pimagedine, blocker of abnormal glucose/protein complexes Indication: Type II diabetics with elevated cholesterol (dyslipidemia) Status: Started Phase II stud...